STREPTOCOCCAL C5a PEPTIDASE VACCINE

Novel vaccines for use against beta -hemolytic Streptococcus colonization or infection are disclosed. The vaccines contain an immunogenic amount of a variant of streptococcal C5a peptidase (SCP). Also disclosed is a method of protecting a susceptible mammal against beta -hemolytic Streptococcus colonization or infection by administering such a vaccine. Enzymatically inactive SCP, and polynucleotides encoding these SCP proteins are further disclosed.

Attached files:
DK 1892298.jpg

Patents:
DK 1,892,298

Inventor(s): CLEARY PAUL PATRICK [US]; STAFSLIEN DEBORAH K [US]

Type of Offer: Licensing



Next Patent »
« More Pharmaceutical Patents

Share on      


CrowdSell Your Patent